Investor Presentation • Mar 25, 2021
Investor Presentation
Open in ViewerOpens in native device viewer
Hannes Niederhauser, CEO Richard Neuwirth, CFO
Earnings Call Presentation March 25, 2021



* Revenues in % of S&T Group total revenues based on location of revenue generating S&T subsidiary
** Source: IMS Report, ABI Research, Oracle, Markets and Markets Analysis

› Guidance 2021:
› Avionics business down by 50%








(in EUR Mio.)

31.12.2019 | 31.12.2020
S&T exceeded its initial FY 2020 Revenue and EBITDA guidance and improved its operating Cash flow significantly


* 3 rd Party revenue including intercompany revenue
** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR 49.6 (FY 2020), MEUR 34.1 (FY 2019)
*** HQ-fee adjusted EBITDA in % of external revenue


* 3 rd Party revenue including intercompany revenue
** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR 66.4 (FY 2020), MEUR 68.2 (FY 2019)
*** HQ-fee adjusted EBITDA in % of external revenue


* 3 rd Party revenue including intercompany revenue
** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR 14.1 (FY 2020), MEUR 9.4 (FY 2019)
*** HQ-fee adjusted EBITDA in % of external revenue

| Mio EUR |
31 12 2020 |
31 12 2019 |
31 12 2020 |
31 12 2019 |
|
|---|---|---|---|---|---|
| NON-CURRENT ASSETS |
506 0 , |
457 2 , |
CAPITAL AND RESERVES |
498 5 , |
385 1 , |
| Fixed Assets |
469 3 , |
422 8 , |
Equity | 409 5 , |
385 1 , |
| as of , plant and equipment Property |
135 1 , |
99 8 , |
as of shares Treasury |
-26 2 , |
-14 6 , |
| as of Goodwill |
199 5 , |
194 4 , |
NON-CURRENT LIABILITIES |
353 8 , |
331 8 , |
| Other Assets |
36 6 , |
34 4 , |
loans and borrowings Long-term |
218 8 , |
220 0 , |
| CURRENT ASSETS |
740 7 , |
768 5 , |
Other Liabilities Non-Current |
135 0 , |
111 8 , |
| Inventories | 159 9 , |
146 8 , |
CURRENT LIABILITIES |
483 4 , |
508 8 , |
| receivables Trade |
204 5 , |
212 1 , |
payables Trade |
210 0 , |
205 0 , |
| from Contract Assets Customers |
23 6 , |
27 2 , |
Liabilities from Contract Customers |
69 7 , |
60 0 , |
| Cash and cash equivalents |
281 9 , |
312 3 , |
Short-term loans and borrowings |
42 8 , |
62 8 , |
| Other receivables and prepayments |
70 9 , |
70 1 , |
Other Liabilities Current |
160 9 , |
181 1 , |
| Total Assets |
1 246 6 , |
1 225 7 , |
Total Liabilities & Equity |
1 246 6 , |
1 225 7 , |
| Equity Ratio |
8% 32 , |
4% 31 , |
|---|---|---|
| Cash/Net Debt* Net |
20 3 , |
29 5 , |
| Working Capital excluding 15** IFRS |
154 3 , |
153 9 , |
* Definition Net Cash: Cash and cash equivalents less non-current and current financing liabilities (excl. liabilities from leasing according to IFRS 16)
** Definition Working Capital: Inventories plus trade receivables less trade payables (excl. IFRS 15 contract assets and liabilities)

OPERATING CASH FLOW (IN EUR MIO.) 26.7 61.4 44.9 35.5 83.4 140.8 0 20 40 60 80 100 120 140 2015 2016 2017 2018 2019 2020
| KPI DEVELOPMENT (IN EUR MIO.) |
|||
|---|---|---|---|
| in EUR Mio. |
2018 | 2019 | 2020 |
| Revenue | 990 | 1,123 | 1,255 |
| Inventory | 74 days (131 Mio.) |
73 days (147 Mio.) |
68 days (160 Mio.) |
| A/R | 75 days (202 Mio.) |
69 days (212 Mio.) |
59 days (205 Mio.) |
| Factoring | 56 Mio. (20%) | 63 Mio. (23%) | 77 Mio. (26%) |


| IN TEUR | EBIT ADJUSTMENTS |
|---|---|
| 68,578 | STATED EBIT |
| -182 | FX losses |
| -414 | One-off M&A expenses |
| -2,508 | Expenses stock options for 2021-2023 years (all recognized in 2020) |
| 5,911 | Corona subsidies (reducing under-utilization effects in lockdowns) |
| -3,220 | Reengineering costs supply chain (Corona) |
| 1,839 | Bad will Iskratel |
| -840 | Restructuring costs North America |
| 4,610 | Release conditional purchase price liability |
| -2,416 | Write-off associated with conditional purchase price |
| -573 | Extraordinary write-offs |
| 2,207 | ONE TIME PROFIT EFFECTS |
| 17,602 | R&D Capitalization |
| -12,649 | R&D Amortization |
| 4,953 | IMPACT R&D CAPITALIZATION |
| -5,908 | P&L effective changes in accruals (see next slide for further details) |
| 67,326 | ADJUSTED EBIT |
| -13,147 | PPA Amortization |
| 80,472 | ADJUSTED EBIT BEFORE PPA |
| IN TEUR | OP. CASHFLOW ADJUSTMENTS |
|---|---|
| 140,812 | STATED OP. CASHFLOW |
| -6,100 | Op. CF contribution from M&A in 2020 (Iskratel/CITYCOMP) |
| -14,558 | Increase in A/R factored from 31.12.2019 to 31.12.2020 |
| -414 | One-off M&A expenses |
| 5,911 | Corona subsidies (reducing under-utilization effects in lockdowns) |
| -3,220 | Reengineering costs supply chain (Corona) |
| -840 | Restructuring costs North America |
| 121,591 | ADJUSTED OP. CASHFLOW |
| ORGANIC GROWTH | |||
|---|---|---|---|
| in TEUR | 2019 | 2020 | |
| Stated revenue | 1,122,885 | 1,254,804 | |
| M&A adjust | -77,786 | ||
| FX adjust | +15,074 | ||
| ORGANIC GROWTH | 6.2% |

ACCRUALS ANALYSIS (in TEUR) P&L impact 2019 2020 Comment TOTAL ACCRUALS no 84,348 67,319 Accruals added by acquisitions no 57,651 * 2,567 * EUR 54 Mio. Kapsch Accruals used via P&L no -24,238 ** -21,600 ** ** EUR 30 Mio. Kapsch Accruals added via P&L yes 9,190 8,110 Accruals released via P&L yes -14,086 -2,202 P&L impact by accrual changes 4,896 *** -5,908 *** ***as of EUR 0.7 Mio. Kapsch
| (in EUR Mio.) | 2019 | in % | 2020 | in % |
|---|---|---|---|---|
| Recurring Revenues | 288 | 25.6 | 344 | 27.4 |
| GEOGRAPHICAL SPLIT 2020 (in %) |
Revenue | EBITDA |
|---|---|---|
| Europe | 78.5% | 81.0% |
| North America | 10.0% | 9.6% |
| Asia | 5.3% | 2.9% |
| RUS/BY/MD | 6.1% | 6.1% |


COMMUTE & TRAVEL
Promotion of train travel, videoconferencing and Home-office work

Expansion of renewable energy usage, e.g. own photovoltaic systems

3 years plan to coordinate ESG topics on group level, clear target to improve ESG Ratings (MSCI to at least BB).

HUMAN DEVELOPMENT More Information on employee development programs

continue to increase share of women in S&T management positions from 21.6% up to 25.6% equaling the current gender distribution in S&T, new female SVB member
Group-wide online compliance training tool to be implemented in 2021

increased audit committee independency since June 2020
New Stock Option Plan for broad employee base established, further initiatives to secure on fair and equal remuneration planned (including new targets/MTI)
| s | 0 --- 100 C |
|---|---|
Intensify communication with "Kleinaktionären", e.g. new shareholder website was set up
| Preparation Reporting expansion ESG-Goal extension ESG-Risk assessment Update Materiality Analysis |
Scope I and II |
Evaluation ESG-Goals Implementation Stage II Improved reporting according to recognised ESG standards |
Implementation Stage III Finalization Continuous |
Improvement Process |
||
|---|---|---|---|---|---|---|
| Stakeholder Dialog | ||||||
| Steps 2021 | Steps 2022 | Steps 2023 | 12 |

| GUIDANCE | 2021 | AGENDA 2023 | |||||
|---|---|---|---|---|---|---|---|
| Revenue: | minimum EUR 1,400 Mio. | 5 years plan | 2018 | 2023p | Growth | ||
| EBITDA: minimum EUR 140 Mio. |
Revenue | 990 Mio. | 2,000 Mio. | +102% | |||
| EPS: minimum 1 Euro |
EBITDA | 90.5 Mio. | 220 Mio | +143% | |||
| EPS | 70 cent | 175 cent | +150% | ||||
| VISION 2030 | |||||||
| Digitalization | SMART Technologies |
To 50% GM | Transformation | M&A Strategy |
Brand Awareness |
Vision 2030: based on product mix transformation GM will exceed 50% and EBITDA margin 15%








| DIVIDEND & SHARE BUYBACKS |
2019 | 2020 | 2021 | Comment |
|---|---|---|---|---|
| Dividend (cent) | 16 | 30 | Dividend for FY 2020 = 1.4% of share price |
|
| Total Dividend (EUR Mio.) | 10.6 | 19.5 | 2019 no dividend (Covid-19 subsidies) | |
| Share Buybacks (EUR Mio.) |
14.6 | 12.2 | 14.1 + X | 2021: already EUR 6.1 Mio. spend |
| TOTAL SPENDINGS (EUR Mio.) |
25.2 | 12.2 | 33.6 + X |


| RECENT DESIGN WINS | COUNTRY | VOLUME EUR | |||
|---|---|---|---|---|---|
| Medical respirator machines | GER | 62 Mio. | |||
| Public contracts | PL | 46 Mio. | |||
| Control for high-speed train | CZ,LIT,DE,FR,UK | 81 Mio. | |||
| AI for robots | GER | 25 Mio. | |||
| Medical surgical robots | USA | 20 Mio. | |||
| TOP CUSTOMERS 2020 | COUNTRY | VOLUME EUR | |||
| Medical respirator machines | GER | 33 Mio. | |||
| Social media compression system | USA | 25 Mio. | |||
| Global leader in medical equipment | USA | 22 Mio. | |||
| Control for high-speed train | UK | 25 Mio. | |||
| Avionics Entertainment System | CN | 16 Mio. | |||
| Top 10 customers for 19% of Revenues, totally >3000 customers |
Medical and Public Sector (Infrastructure) drive current growth | Assumed impact from chip shortage only on Q1 2021 revenues


| Backlog EUR Mio. |
12/14 | 12/15 | 12/16 | 12/17 | 12/18 | 12/19 | 12/20 | CONTINOUS | GROSS MARGIN AND EBITDA MARGIN GROWTH | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Project Pipeline | 644 | 701 | 1,002 | 1,105 | 1,632 | 2,158 | 2,702 | GM | 33.0 % | 33.9 % | 33.5% | 35.7 % | 35.0% | 36.3% | 36.3% | > 37% |
| Scheduled Orders | 157 | 181 | 306 | 474 | 841 | 841 | 927 | EBITDA | 5.9% | 6.0% | 6.8% | 7.7% | 9.1% | 9.9% | 10.4% | > 10.4 |
Guidance 2021: min. EUR 1,400 Mio. Revenue – min. EUR 140 Mio. EBITDA – min EPS 1 Euro
* vs current FC FY 2020 19

› Revenue growth of 12% and EBITDA growth of 16%




Due to the end of Corona subsidies, we see good opportunities to acquire small companies at particularly favorable conditions. Currently we have several in the pipeline (revenue EUR 5-10 million) with very small purchasing prices.

› INVESTOR QUESTION: Did you downsize the past acquisitions? I come to a higher contribution than the EUR 78 million you communicated.
› INVESTOR QUESTION: 0.4 times revenue is the price target you named last year. Do you expect prices to increase because the valuations on the stock market are higher now?

› INVESTOR QUESTION: Looking at the 2020 cash flow statement the change in net cash amounts to EUR 39 Mio. The net cash position (excluding lease liabilities) reduced by EUR 9 Mio. compared to 31.12.2019. There appears to be a discrepancy between generating EUR 39 Mio. of cash flow, yet the net cash position falls by EUR 10 Mio?
| INVESTOR CASH FLOW CALCULATION | 2020 | |
|---|---|---|
| Op. CF | 141 | |
| CF from Investments |
-77 | |
| Interest | -6 | |
| Aquisition Cost | -8 | |
| Share Buyback | -12 | |
| Capital Increase | 1 | |
| Change in Net Cash from CF Statement | 39 | |
| INVESTOR NET CASH CALCULATION | 2020 | 2019 |
| Cash | 282 | 312 |
| Gross Debt current | -43 | -63 |
| Gross Debt long-term |
-219 | -220 |
| Net Cash | 20 | 29 |
| Change in Net Cash | -9 | |
| S&T CASH FLOW CALCULATION | 2020 | |
|---|---|---|
| Change in Net Cash from CF Statement | 39 | |
| Leasing payments | -22 | |
| Reduction of overdrafts |
-19 | |
| Net FX and Other Effects | -7 | |
| Change in Net Cash | -9 | |

This document includes 'forward-looking statements'. Forward-looking statements are all statements, which do not describe facts of the past, but containing the words "believe", "estimate", "expect", "anticipate", "assume", "plan", "intend", "could", and words of similar meaning. These forward-looking statements are subject to inherent risks and uncertainties since they relate to future events and are based on current assumptions and estimates of S&T AG, which might not occur at all or occur not as assumed. They therefore do not constitute a guarantee for the occurrence of future results or performances of S&T AG. The actual financial position and the actual results of S&T AG, as well as the overall economic development and the regulatory environment may differ materially from the expectations, which are assumed explicitly or implicitly in the forward-looking statements and do not comply to them. Analysts and investors, and any other person or entity that may need to take decisions or prepare or release opinions about the shares / securities issued by S&T AG are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date of this document. Past performance cannot be relied upon as a guide to future performance.
Except as required by applicable law, S&T AG undertakes no obligation to revise these forward-looking statements to reflect events and circumstances after the date of this presentation, including, without limitation, changes in S&T's business or strategy or to reflect the occurrence of unanticipated events. The financial information and opinions contained in this document are unaudited and are subject to change without notice. This document contains summarized information or information that has not been audited. In this sense, this information is subject to, and must be read in conjunction with, all other publicly available information, including if it is necessary, any fuller disclosure document published by S&T AG. None of the Company, its subsidiaries or affiliates or by any of its officers, directors, employees, advisors, representatives or agents shall be liable whatsoever for any loss however arising, directly or indirectly, from any use of this document its content or otherwise arising in connection with this document.
This document or any of the information contained herein do not constitute, form part of or shall be construed as an offer or invitation to purchase, subscribe, sale or exchange, nor a request for an offer of purchase, subscription, sale or exchange of shares / securities of S&T AG, or any advice or recommendation with respect to such shares / securities. This document or a part of it shall not form the basis of or relied upon in connection with any contract or commitment whatsoever.
This document does not constitute an offer to purchase securities in the United States, Canada, Australia, South Africa and Japan. Securities, including the bond of S&T AG may not be sold or offered for sale within the United States or to or for the account of / in favor of US citizens (as defined in Regulation S under the U.S. Securities Act of 1933 in the current version (the "Securities Act") unless they are registered under the regulations of the Securities Act or unless they are subject to an exemption from registration. Neither S&T AG nor any other person intend to register the offer or a part thereof in the United States or to make a public offer of the securities in the United States.
| APPENDIX |
|---|
| ORGANIC GROWTH |
| ORGANIC GROWTH in TEUR |
2019 | 2020 | |
|---|---|---|---|
| Comments | |||
| Stated revenue | 1,122,885 | 1,254,804 | |
| M&A adjust | |||
| Iskratel | 35,180 | ||
| Citycomp | 17,175 | ||
| Cronos | 681 | ||
| Kapsch Transportation |
70,308 | 98,608 | |
| BASS | 10,357 | 8,228 | |
| AIS Automation | 2,799 | 14,601 | |
| KAD | 5,375 | 2,252 | Stop SEA region |
| Gada | 14995 | 4,895 | divest PH Business in RO |
| USD FX effect, EUR = 1,123 -> 1,227 | -15,074 | 32% invoiced in USD |
|
| Adjusted Revenues | 1,016,146 | 1,192,092 | |
| ORGANIC GROWTH | 6.2% | ||



For our M&A activities we are looking for interested interim managers for integration phase
Christoph Neumann VP
Technology
* Definition EBITDA Interest Coverage Ratio: EBITDA divided by interest expenses (excl. interest expenses related to leasing liabilities according to IFRS 16)
** Definition Net Cash: Cash and cash equivalents less non-current and current financing liabilities (excl. liabilities from leasing according to IFRS 16)
*** Definition Working Capital: Inventories plus trade receivables less trade payables (excl. IFRS 15 contract assets and liabilities)
| In Mio. EUR | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenues | 503.7 | 882.0 | 990.9 | 1,122.9 | 1,254.8 |
| Gross Profit |
168.9 | 315,0 | 346.5 | 407.5 | 455,8 |
| Gross Margin | 33.5% | 35.7% | 35.0% | 36.3% | 36,3% |
| EBITDA | 34.4 | 68.1 | 90.5 | 111.7 | 130.0 |
| EBITDA Margin | 6.8% | 7.7% | 9.1% | 9.9% | 10.4% |
| EBIT before PPA amortization | 28.2 | 47.9 | 67.3 | 67.2 | 81.7 |
| Net Income after NCI |
20.4 | 29.4 | 48.5 | 49.1 | 55.6 |
| EBITDA Interest Coverage Ratio* | 7.9 | 9.8 | 14.5 | 12,4 | 14,0 |
| Net Cash ** | 32.0 | 101.8 | 52.7 | 29.5 | 20.3 |
| Working Capital *** |
119.2 | 121.5 | 156.4 | 153.9 | 154.3 |
| Equity Ratio | 36.0% | 41.2% | 43.3% | 31.4% | 32.8% |
| Operating Cash flow | 61.4 | 44.9 | 35.5 | 83.4 | 140.8 |
| Employees | 3,786 | 3,849 | 4,248 | 4,934 | 6.067 |

27

Industriezeile 35
A-4021 Linz
www.snt.at
IR Contact:
+43 (1) 80191 - 1196
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.